ESTIV 2008 - European Society of Toxicology In Vitro
15th International Congress on In Vitro Toxicology, 25 to 28 Sept 2008, Stockholm, Sweden

ESTIV 2008 congress is a joint venture organized by ESTIV (European Society of Toxicology In Vitro), SSCT (Scandinavian Society for Cell Toxicology) and Expertradet ECB Environmental Competence Ltd. ESTIV 2008 will be held September 25-28 in Stockholm, Sweden.

The scientific program will include state-of-the-art lectures, workshops and poster sessions. The congress will cover topics such as in vitro models for environmental toxicology, new in vitro models and strategies, in vitro models for tissue-specific toxicity and toxicokinetics. Sessions dealing with progress in implementation of alternative tests and new approaches in validation are also included in the program.

MatTek Scientists will contribute to the scientific program with following presentations (please click on the presentation title to view the abstract in PDF):

ORAL Presentations:

POSTER Presentations:


Life quality through better use of research


The proceedings of the ESTIV 2008 Congress will be published in 'Toxicology in Vitro'. All participants giving an invited lecture, an oral presentation or a poster presentation are entitled
to submit a manuscript related to their presentation which will be considered for publication.

Bas Blaauboer will be the coordinating editor, assisted by two members of the Scientific Committee. The co-editors will arrange for the manuscripts to undergo regular peer-review by two reviewers and, following satisfactory revision where appropriate, will forward the manuscripts to the journal with the recommendation that they should be accepted for publication.

Please note that manuscripts must be submitted online until November 1, 2008, in order to avoid delays in publication of the proceedings. It is planned to publish the papers in about 14 weeks of receipt of the final accepted material.


Manuscript preparation guidelines

All manuscripts must conform to the standards set out in the Guide for Authors for the journal.

A limit has been set to the total length of the submitted manuscripts. For all presenters the total number of pages should not exceed 15 pages (double spaced, 12 pt font), including tables, figures and references.


Online submission guidelines

Manuscripts must be submitted via the Elsevier Editorial system (EES).

Please note that all manuscripts must be submitted to the special section of the EES that has been set up for SSCT 2007 by selecting 'ESTIV 2008' as article type in the drop down menu.

Poster Presentation Instructions


1. Installation of posters is possible from Thursday 25 September 2008, 12.00 and posters have to be taken off at the latest until Sunday 28 September, 2008, 14.00. Posters which will not be removed, will be dissolved.

2. Posters will be on display in the Poster Area. There will be several occasions to discuss the posters (see the congress programme).

3. Poster boards’ dimensions will be 90 cm in width and 190 cm in height. Recommended dimensions of the posters are 90 cm wide x 120 cm high.

4. Material for mounting posters will be provided in the poster area.

5. Posters should be brought to the meeting by the authors.

6. Authors are requested to be present at their posters during the poster session for which their poster has been scheduled (see the congress programme).

7. A headline strip on the poster should include the title, authors, organizations and addresses.

8. The poster should contain: Introduction, Method, Results and Discussion. The data should be understandable without oral explanation.

9. Posters should be designed in a way that everything is readable from a distance.

More money to the research!


In his opening speech at the ESTIV2008 Congress promised Lars Leijonborg, The Swedish Minister of Education and Higher Research, more money to the research.


Read his speech from the opening of the congress below:

Therefore, the Swedish Government has recently proposed investments in research and innovation which will entail successive increases in central government support during the period 2009-2012, to reach a permanent increase of 5 billion Swedish Crowns in 2012. The largest increases will benefit research into medicine, technology and the climate.

I am proud to say that this is the largest, single extra investment ever to have been made in Swedish research! The investment is also considerable by international standards. And despite the fact that many countries in the European Union have expressed the ambition to reach the one-per-cent goal in accordance with the Lisbon strategy, few countries have actually, like Sweden, made binding budget decisions to that effect.

I would also like to mention that since 1981, the Swedish Government has provided funding for research to develop alternatives to animal experiments. From 2009 the budget for this purpose will increase.

To conclude: I have read that within the aims and purposes of this congress, you will explore new technical and scientific challenges with respect to in vitro toxicology. A lot of people in many countries are following your efforts with high expectations. I  would like to wish you good luck in your important work!